Saltar al contenido

Maxim Cherkashin

@mcherkashin.bsky.social did:plc:zgasssvhe24bpaobvffjus2b

Once did an experiment, and can't stop. Postdoc: sonicating things to help light get through them, photoacoustics, biomedical optics, Dad of 2 Takes in: coffee and music, outputs: questions

En Bluesky desde el

Seguidores
849
Siguiendo
968
Posts
881
Días en rankings
0

Resumen

Maxim Cherkashin (@mcherkashin.bsky.social) es un usuario de Bluesky que se unió el 16 septiembre 2023. Tiene 849 seguidores, sigue a 968 cuentas y ha publicado 881 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • Daniel Bellingradt@dbellingradt.bsky.social

    While some of you mention this in emails, another funding grant like ERC is not a solution for me. I already have secured lots of funding, and it was fun doing so. Another new grant would just secure another 3-5 years of payment, and that’s it. Academia needs jobs, and not more funding options.

    Ver post
  • Daniel Bellingradt@dbellingradt.bsky.social

    These days, I am declining review requests, invitations to conferences, keynotes, and publication projects. I feel sorry for my communities and myself, but my current academic job is ending in a not so far future. 2027 will be my 17th year as a postdoc, and 13th year of being a fixed-term professor.

    Ver post
  • SPIE@spie.org

    The 2027 SPIE Prism Awards finalists are in! 🏆 21 finalists across seven photonics categories, plus two SPIE Catalyst Award finalists: Lumentum and Red Pitaya. 💡 Congratulations to all! Winners will be announced on 3 February at #PhotonicsWest. Meet the finalists: https://bit.ly/4BYNqr8

    Ver post
  • Christophe 🔬 Leterrier@christlet.bsky.social

    Love (and music) will save the world!

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.